1 July 2024
EMBL Announcements
EMBL and partners announce ‘Amplifying Funds in Infection Biology’ to foster interdisciplinary and collaborative research in infection biology.
27 June 2024
Science & Technology
EMBL researchers and their partners have been studying microbial functions and interactions for the benefit of human and planetary health for the last two decades.
7 June 2024
Perspectives, Science & Technology
EMBL-EBI data resource helps scientists upcycle animal by-products.
2024
perspectivesscience-technology
5 February 2024
Lab Matters, People & Perspectives
Jacqueline shares her experience of EMBL's international PhD programme.
2024
lab-matterspeople-perspectives
27 November 2023
Science, Science & Technology
An interdisciplinary collaboration between Hamburg scientists has yielded new insights into the structure and function of a heat-resistant enzyme from an exotic microbe. In this interview, EMBL Hamburg’s Matthias Wilmanns and TUHH’s Garo Antranikian discuss how their collaboration developed and…
2023
sciencescience-technology
26 October 2023
EMBL Announcements, Science
Jan Kosinski, Julia Mahamid, and Georg Zeller have received grants to enable ambitious projects aimed at mapping the cellular protein synthesis machinery in context and understanding complex host-microbiome interactions, respectively.
2023
embl-announcementsscience
20 October 2023
Events, Science & Technology
Here are six takeaways from a recent EMBO/EMBL symposium that brought together scientists to discuss the state of research involving the human microbiome and its connection to health and disease.
2023
eventsscience-technology
17 October 2023
Science, Science & Technology
In an extensive investigation, EMBL researchers have tested over 10,000 drug combinations against some of the leading pathogenic bacteria carrying antimicrobial resistance and causing mortality.
2023
sciencescience-technology
5 September 2023
EMBL Announcements, Lab Matters
Jordi van Gestel and Maria Zimmermann-Kogadeeva each receive 1.5 million EUR funding for research projects on microbial predators and the gut microbiome respectively
2023
embl-announcementslab-matters
14 August 2023
People & Perspectives, Perspectives, Science
EMBL-EBI Senior Scientist Rob Finn explains why data coordination and sharing are fundamental for a sustainable blue economy.
2023
people-perspectivesperspectivesscience
27 June 2023
Science, Science & Technology, Technology and innovation
HoloFood, the first consistent collection of multiomic data about chicken and salmon gut microbiomes, set to enable the development of better animal feeds.
2023
sciencescience-technologytechnology-and-innovation
19 April 2023
People & Perspectives, Perspectives
As a postdoc Alex Almeida used bioinformatics to push the boundaries of what we know about the gut microbiome. Here, Almeida explains how his time at EMBL-EBI generated new research avenues, and how the skills and connections from his postdoc prepared him for leading his own research group at the…
2023
people-perspectivesperspectives
11 January 2023
Lab Matters, People & Perspectives
Rob Finn, one of the co-chairs of the Microbial Ecosystems theme, discusses his work, the challenges of multidisciplinary research, and how the theme is already helping to promote the exchange of scientific ideas.
2023
lab-matterspeople-perspectives
22 November 2022
EMBL Announcements, Lab Matters
Three EMBL scientists received this year’s ERC Starting Grants, and will be awarded €1.5 million over five years to carry out research projects.
2022
embl-announcementslab-matters
21 November 2022
Lab Matters, People & Perspectives
Looking to understand microbial predator-prey relationships, EMBL’s newest group leader tackles a molecular ‘arms race’ in his lab.
2022
lab-matterspeople-perspectives
15 September 2022
Science, Science & Technology
EMBL researchers used data from over 300 human faecal microbiota transplants to gain an ecological understanding of what happens when two gut microbiomes clash.
2022
sciencescience-technology
1 August 2022
Research highlights, Science, Science & Technology
Machine learning has helped researchers uncover new insights into how bacteria infect host cells.
2022
research-highlightssciencescience-technology
18 July 2022
Science, Science & Technology
EMBL researchers now understand the function of an elusive small DNA in bacteria and have developed a tool that can be used to better understand what might ‘switch on’ bacterial immune defences.
2022
sciencescience-technology
6 July 2022
EMBL Announcements, Lab Matters
Cornelius Gross, Miki Ebisuya and Nassos Typas join EMBO, the prestigious organisation for the life sciences.
2022
embl-announcementslab-matters
7 June 2022
Lab Matters, People & Perspectives
Pascale Cossart, one of the world’s foremost authorities on the biology of Listeria, brings four decades of expertise in intracellular bacterial parasitism to EMBL as a visiting scientist.
2022
lab-matterspeople-perspectives
30 March 2022
Lab Matters, People & Perspectives
John Lees joins EMBL-EBI as a Group Leader in Pathogen informatics and modelling.
2022
lab-matterspeople-perspectives
19 January 2022
Announcements, EMBL Announcements, Lab Matters
EMBL announces details about its next programme, ‘Molecules to Ecosystems’. It will guide studying life across scales and in context with changing environments.
2022
announcementsembl-announcementslab-matters
25 November 2021
Lab Matters, People & Perspectives
Maria Zimmermann-Kogadeeva is one of EMBL’s newest group leaders and a computational biologist whose research group applies computational modelling to better understand the metabolism of gut bacteria and their potential to have far-reaching impacts on other organs.
2021
lab-matterspeople-perspectives
13 October 2021
Science, Science & Technology
Researchers from EMBL’s Typas group and collaborators have analysed the effects of 144 antibiotics on the wellbeing of gut microbes. The study improves our understanding of antibiotics’ side effects and suggests a new approach to mitigating the adverse effects of antibiotics therapy on gut…
2021
sciencescience-technology
8 September 2021
Science, Science & Technology
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
2021
sciencescience-technology
1 June 2021
Connections, Lab Matters
EMBL and the Swedish Science for Life Laboratory sign agreement to advance science together.
2021
connectionslab-matters
No matching posts found